-
PUBLICATION
2023.09.28
SMC is proud to announce that Dong-A ST Co., Ltd. (KOR) has published the results of their study using our pre-clinical services with the STAM™ mice in Biomed Pharmacother.
-
NEWS RELEASE
2023.09.22
The U.S. FDA has granted Breakthrough Therapy Designation (BTD) for 89bio, Inc.'s pegozafermin, a new drug candidate for non-alcoholic steatohepatitis (NASH).
-
UPCOMING EVENTS
SMC at BioJapan 2023 in October!
2023.09.15
We are pleased to announce that SMC Laboratories will be attending the BioJapan 2023 from October 11th (Wed) to 13th (Fri).